Primecap Management CO Novartis Ag Transaction History

Primecap Management CO

  • $132 Billion
  • Q1 2024

A detailed history of Primecap Management CO transactions in Novartis Ag stock. As of the latest transaction made, Primecap Management CO holds 12,417,755 shares of NVS stock, worth $1.28 Billion. This represents 0.91% of its overall portfolio holdings.

Number of Shares
12,417,755
Previous 12,905,697 3.78%
Holding current value
$1.28 Billion
Previous $1.3 Billion 7.82%
% of portfolio
0.91%
Previous 1.04%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
SELL
$95.27 - $108.47 $46.5 Million - $52.9 Million
-487,942 Reduced 3.78%
12,417,755 $1.2 Billion
Q4 2023

Feb 09, 2024
SELL
$92.27 - $101.54 $156 Million - $172 Million
-1,689,455 Reduced 11.58%
12,905,697 $1.3 Billion
Q3 2023

Nov 13, 2023
SELL
$94.73 - $105.13 $39.4 Million - $43.7 Million
-415,523 Reduced 2.77%
14,595,152 $1.49 Billion
Q2 2023

Aug 11, 2023
SELL
$92.52 - $104.91 $131 Million - $149 Million
-1,416,360 Reduced 8.62%
15,010,675 $1.51 Billion
Q1 2023

May 15, 2023
SELL
$80.03 - $92.81 $61.5 Million - $71.3 Million
-767,845 Reduced 4.47%
16,427,035 $1.51 Billion
Q4 2022

Feb 13, 2023
SELL
$75.55 - $92.52 $19.5 Million - $23.9 Million
-258,270 Reduced 1.48%
17,194,880 $1.56 Billion
Q3 2022

Nov 14, 2022
SELL
$74.61 - $87.26 $11.3 Million - $13.2 Million
-150,930 Reduced 0.86%
17,453,150 $1.33 Billion
Q2 2022

Aug 11, 2022
SELL
$80.52 - $93.75 $14.5 Million - $16.9 Million
-180,650 Reduced 1.02%
17,604,080 $1.49 Billion
Q1 2022

May 11, 2022
SELL
$80.11 - $90.62 $30.5 Million - $34.5 Million
-380,860 Reduced 2.1%
17,784,730 $1.56 Billion
Q4 2021

Feb 11, 2022
SELL
$79.7 - $88.13 $71.4 Million - $79 Million
-896,060 Reduced 4.7%
18,165,590 $1.59 Billion
Q3 2021

Nov 12, 2021
SELL
$81.78 - $95.14 $18 Million - $20.9 Million
-220,200 Reduced 1.14%
19,061,650 $1.56 Billion
Q2 2021

Aug 10, 2021
SELL
$85.24 - $94.15 $108 Million - $119 Million
-1,261,950 Reduced 6.14%
19,281,850 $1.76 Billion
Q1 2021

May 14, 2021
SELL
$83.5 - $98.47 $105 Million - $124 Million
-1,261,650 Reduced 5.79%
20,543,800 $1.76 Billion
Q4 2020

Feb 08, 2021
SELL
$78.07 - $94.43 $59.8 Million - $72.3 Million
-765,490 Reduced 3.39%
21,805,450 $2.06 Billion
Q3 2020

Nov 13, 2020
SELL
$82.14 - $91.0 $57.2 Million - $63.4 Million
-696,330 Reduced 2.99%
22,570,940 $1.96 Billion
Q2 2020

Aug 13, 2020
SELL
$80.93 - $91.1 $61.6 Million - $69.3 Million
-761,070 Reduced 3.17%
23,267,270 $2.03 Billion
Q1 2020

May 14, 2020
SELL
$70.67 - $99.01 $102 Million - $143 Million
-1,444,010 Reduced 5.67%
24,028,340 $1.98 Billion
Q4 2019

Feb 14, 2020
SELL
$84.35 - $95.37 $5.68 Million - $6.42 Million
-67,350 Reduced 0.26%
25,472,350 $2.41 Billion
Q3 2019

Nov 13, 2019
SELL
$85.54 - $94.26 $6.67 Million - $7.35 Million
-77,940 Reduced 0.3%
25,539,700 $2.22 Billion
Q2 2019

Aug 14, 2019
BUY
$75.4 - $92.8 $133 Million - $163 Million
1,760,424 Added 7.38%
25,617,640 $2.34 Billion
Q1 2019

May 14, 2019
BUY
$75.32 - $86.15 $73.1 Million - $83.6 Million
969,985 Added 4.24%
23,857,216 $2.29 Billion
Q4 2018

Feb 12, 2019
BUY
$73.66 - $82.02 $47.5 Million - $52.9 Million
645,510 Added 2.9%
22,887,231 $1.96 Billion
Q3 2018

Nov 13, 2018
BUY
$66.94 - $77.43 $7.4 Million - $8.56 Million
110,563 Added 0.5%
22,241,721 $1.92 Billion
Q2 2018

Aug 13, 2018
BUY
$64.91 - $73.36 $20.3 Million - $22.9 Million
312,686 Added 1.43%
22,131,158 $1.67 Billion
Q1 2018

May 14, 2018
SELL
$70.39 - $84.15 $5.08 Million - $6.07 Million
-72,152 Reduced 0.33%
21,818,472 $1.76 Billion
Q4 2017

Feb 13, 2018
SELL
$72.33 - $77.64 $5.36 Million - $5.76 Million
-74,140 Reduced 0.34%
21,890,624 $1.84 Billion
Q3 2017

Nov 13, 2017
BUY
$74.14 - $77.27 $1.63 Billion - $1.7 Billion
21,964,764
21,964,764 $1.89 Billion

Others Institutions Holding NVS

# of Institutions
1,342
Shares Held
140M
Call Options Held
1.15M
Put Options Held
866K
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $222B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Primecap Management CO Portfolio

Follow Primecap Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Primecap Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Primecap Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email